HopeStageGet research updates
HopeStage
hi@hopestage.com

Built by people with lived experience, between Sydney and Paris.

Back to all studies
RecruitingEUCTR 2022-003670-22

Controlled and randomized clinical trial to evaluate the efficacy of the combination of oxytocin plus self-compassion training in patients with Borderline Personality Disorder Ensayo clínico controlado y aleatorizado para evaluar la eficacia de la combinación de oxitocina más entrenamiento en autocompasión en pacientes con Trastorno Límite de Personalidad

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Personality disorders, Borderline personalityDrug
In plain English

Key information made simple

What the source confirms

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

What should you check before joining?

Check the official protocol for eligibility, treatment, visits and assessments. If recruitment is listed, confirm with the team that a specific centre is still accepting participants before taking any next step.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View the historical EU CTR record (opens in a new tab)

  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateNot clearly listed
Recruitment status
Recruiting
Enrollment listed in the registry
Not clearly listed
Sponsor
Institut de Recerca Hospital de la Santa Creu i Sant Pau - IIB Sant Pau
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
Spain
Age range
Not clearly listed
Official registry ID
EUCTR 2022-003670-22
Official title
Controlled and randomized clinical trial to evaluate the efficacy of the combination of oxytocin plus self-compassion training in patients with Borderline Personality Disorder Ensayo clínico controlado y aleatorizado para evaluar la eficacia de la combinación de oxitocina más entrenamiento en autocompasión en pacientes con Trastorno Límite de Personalidad

Want help reviewing this study?

Loading the security check...
Study ID: EUCTR 2022-003670-22. We help you review the study, but cannot decide medical eligibility.

Recruitment & locations

Recruiting

Barcelona

Checked Official study record (opens in a new tab)
Registry detailsOriginal registry record (opens in a new tab)
Registry conditions (original wording)

Borderline personality disorder Trastorno Límite de la Personalidad

Current country statuses
  • Spain — Ongoing, recruiting
Historical country statuses
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Institut de Recerca Hospital de la Santa Creu i Sant Pau - IIB Sant Pau, a hospital or academic medical center.

Is this study still recruiting?

The registry lists this study as recruiting.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.